• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [967 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2023 NIHR Health Services and Delivery Research programme Towards achieving interorganisational collaboration between health-care providers: a realist evidence synthesis
2023 NIHR Health Services and Delivery Research programme Youth violence intervention programme for vulnerable young people attending emergency departments in London: a rapid evaluation
2023 Malaysian Health Technology Assessment (MaHTAS) Bio-electrical impedance analysis for the assessment of sarcopenia in elderly
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: implantable medical device tracking methods]
2023 NIHR Health Technology Assessment programme Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
2023 Malaysian Health Technology Assessment (MaHTAS) Human skin allograft for burns
2023 Malaysian Health Technology Assessment (MaHTAS) Negative pressure wound therapy
2023 Health Information and Quality Authority (HIQA) Expansion of the childhood immunisation schedule to include varicella (chickenpox) vaccination: health technology assessment
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optical genome mapping - diagnosis and prognostic stratification of hematological malignancies]
2023 WorkSafeBC Causal association between carpal tunnel release surgery and trigger finger
2023 WorkSafeBC Esketamine as treatment for depression and PTSD
2023 WorkSafeBC Migraines and the (Moderna) COVID-19 vaccine
2023 WorkSafeBC Causal association between COVID-19 infection and irritable larynx syndrome
2023 WorkSafeBC Flotation therapy as treatment for concussions
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: service trajectories and services for at risk or neglected children and their families]
2022 Center for Drug Evaluation (CDE) The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography angiography in vascular eye diseases]
2022 NIHR Health Technology Assessment programme Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 1 - overview of heart and lung transplantation in Québec]
2022 Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous transvascular implantation of a coronary sinus reducing stent. Update 2022
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 3 - overview of renal and pancreatic transplantation in Québec]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: chronic obstructive pulmonary disease- detection, diagnosis, optimal use of medications and inhalation devices, and global management]
2022 Belgian Health Care Knowledge Centre (KCE) Evaluation of Shingrix vaccine against herpes zoster
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cardiac monitoring with textile wearable Holter for atrial fibrillation detection after cryptogenic stroke]
2022 WorkSafeBC N-acetylcysteine (NAC) as treatment for complex regional pain syndrome (CRPS): 2022 Update
2022 WorkSafeBC Balloon spacer as treatment for massive rotator cuff tear
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Efficacy and safety of transanal irrigation in adults with bowel dysfunction]
2022 Malaysian Health Technology Assessment (MaHTAS) Immunotherapy for PD-L1 positive advanced non-small cell lung cancer
2022 NIHR Health Technology Assessment programme Moulded cast compared with K-wire fixation after manipulation of an acute dorsally displaced distal radius fracture: the DRAFFT 2 RCT
2022 Malaysian Health Technology Assessment (MaHTAS) Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for non-small cell lung cancer
2022 WorkSafeBC Dupuytren's contracture and wrist fractures
2022 WorkSafeBC Ketamine infusion therapy for hyperalgesia and or central sensitivity pain
2022 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2022 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Assessment and clinical management of self-harm in adolescence: evidence-based protocol]
2022 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Delamanid (repeal of the exemption: pulmonary multi-drug resistant tuberculosis, ≥ 10 kg)]
2022 Malaysian Health Technology Assessment (MaHTAS) Early cancer detection test for lung (EarlyCDT-Lung)
2022 WorkSafeBC Vision therapy as treatment for traumatic brain injury: 2022 update
2022 NIHR Health Services and Delivery Research programme Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations
2022 WorkSafeBC Inpatient versus outpatient programs as treatment for PTSD
2022 WorkSafeBC Oral collagen supplements for shoulder sprain strain
2022 Malaysian Health Technology Assessment (MaHTAS) First line targeted therapy for advanced hepatocellular carcinoma (aHCC)
2022 WorkSafeBC Lose-dose naltrexone as treatment for post-COVID conditions
2022 Basque Office for Health Technology Assessment (OSTEBA) [Autism spectrum disorder: scientific evidence on its detection, diagnosis and treatment]
2022 Malaysian Health Technology Assessment (MaHTAS) Transcutaneous oxygen pressure monitoring (TcPO2)
2022 Malaysian Health Technology Assessment (MaHTAS) Sublingual immunotherapy (SLIT) for atopy (allergic rhinitis, eczema and asthma)
2022 Malaysian Health Technology Assessment (MaHTAS) Mesenchymal stem cells for retinitis pigmentosa and other degenerative retina disease
2022 WorkSafeBC Efficacy and/or effectiveness of treatments for lateral epicondylitis - barbotage and ultrasonic tenotomy
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 2 - overview of liver transplantation in Québec]
2022 Health Sciences Institute in Aragon (IACS) [Digital dermatoscopy]
2022 Swiss Federal Office of Public Health (FOPH) Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction
2022 NIHR Public Health Research (PHR) programme E-health interventions targeting STIs, sexual risk, substance use and mental health among men who have sex with men: four systematic reviews
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: a look at Québec’s family medicine groups and a proposal to segment the population to support continuous quality improvement approaches based on health needs]
2022 Swiss Federal Office of Public Health (FOPH) Levothyroxine for patients diagnosed with subclinical hypothyroidism
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: organization of care and services for the prevention and management of post COVID-19 conditions]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: helicopter emergency medical services (HEMS) - needs analysis and clientele identification]
2022 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Migalastat (new therapeutic indication: Fabry disease, 12 to < 16 years)]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: updated recommendations for adjusting antidiabetic medication in type 2 diabetes]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of the relevance of newborn screening for severe combined immunodeficiency SCID]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: relevance of the prerequisite of the use of an immunosuppressant drug for the coverage of biologic agents (gastroenterology and dermatology)]
2022 NIHR Health Services and Delivery Research programme Assessment and management pathways of older adults with mild cognitive impairment: descriptive review and critical interpretive synthesis
2022 Health Information and Quality Authority (HIQA) Health technology assessment of metabolic surgery for the treatment of comorbid type 2 diabetes and obesity
2022 NIHR Health Technology Assessment programme One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Sialendoscopy for obstructive salivary gland disease]
2022 Austrian Institute for Health Technology Assessment (AIHTA) Long COVID care pathways and structures: an updated scoping review
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Casirivimab and imdevimab to treat Covid-19 in patients negative for the Omicron genotype]
2021 Austrian Institute for Health Technology Assessment (AIHTA) Long COVID care pathways: a systematic review
2021 Center for Drug Evaluation (CDE) Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
2021 WorkSafeBC Acupuncture or massage therapy as treatment for occipital neuralgia
2021 Andalusian Health Technology Assessment Area (AETSA) [18F-FDG in myocardial viability for revascularization]
2021 Andalusian Health Technology Assessment Area (AETSA) [Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2021 NIHR Health Services and Delivery Research programme Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review
2021 NIHR Health Technology Assessment programme Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model
2021 Andalusian Health Technology Assessment Area (AETSA) [High intensity focused ultrasound (HIFU) in organ-confined prostate tumors]
2021 Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with neoadjuvant chemotherapy for HER2-positive breast cancer and economic evaluation
2021 Malaysian Health Technology Assessment (MaHTAS) Therapeutic drug monitoring (TDM) for anti-tuberculosis
2021 Malaysian Health Technology Assessment (MaHTAS) Mobile C-arm fluoroscopy for cardiothoracic surgery
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of newborn screening for spinal muscular atrophy]
2021 Swiss Federal Office of Public Health (FOPH) Effectiveness and safety of vitamin B12 tests
2021 Malaysian Health Technology Assessment (MaHTAS) Viscoelastic haemostatic assay for non-cardiac surgery
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: organization of care and services related to alternate levels of care (ALC)]
2021 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Sentinel lymph node biopsy in oral cavity carcinoma: clinical effectiveness, safety, and cost-effectiveness]
2021 Adelaide Health Technology Assessment (AHTA) Small gene panel testing for non-small cell lung carcinoma
2021 Adelaide Health Technology Assessment (AHTA) Whole genome sequencing of antimicrobial-resistant pathogens
2021 The Regional Health Technology Assessment Centre (HTA-centrum) Efficacy and safety of endovascular versus surgical arteriovenous fistula creation for hemodialysis
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: artificial intelligence-assisted diabetic retinopathy tele-screening]
2021 Malaysian Health Technology Assessment (MaHTAS) Driving simulator in healthcare
2021 NIHR Health Technology Assessment programme Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study
2021 NIHR Health Technology Assessment programme Feasibility of a RCT of techniques for managing an impacted fetal head during emergency caesarean section: the MIDAS scoping study
2021 Malaysian Health Technology Assessment (MaHTAS) Delirium unit in geriatric ward
2021 Malaysian Health Technology Assessment (MaHTAS) Digital assisted oral & cranio-maxillofacial surgery
2021 Norwegian Institute of Public Health (NIPH) Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment
2021 Malaysian Health Technology Assessment (MaHTAS) Rezūm therapy for management of benign prostatic hyperplasia
2021 Malaysian Health Technology Assessment (MaHTAS) 5-aminolevulinic acid (5-ALA) for brain tumour surgical procedure
2021 Malaysian Health Technology Assessment (MaHTAS) Single dose rifampicin (SDR) as a prophylaxis for leprosy contacts
2021 NIHR Health Services and Delivery Research programme Respite care and short breaks for young adults aged 18–40 with complex health-care needs: mixed-methods systematic review and conceptual framework development
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Whole-exome sequencing in patients with neurological disorders]
2021 Belgian Health Care Knowledge Centre (KCE) Do innovative medicines against cancer always have a real added value?
2021 Institute for Clinical Effectiveness and Health Policy (IECS) [Whole exome sequencing in epileptic encephalopathies]
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Lyme disease and persistent symptoms: a look at the current knowledge and recommendations for improving management]
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: chronic” Lyme disease: current state of knowledge and overview of the different perspectives]